NDAORALTABLET
Approved
Jul 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Mechanism of Action
Dihydrofolate Reductase Inhibitors
Pharmacologic Class:
Dihydrofolate Reductase Inhibitor Antibacterial
Clinical Trials (2)
A Non-Interventional Safety Study of Balsamic Bactrim
Started Nov 2016
52 enrolled
Bronchitis
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
Started Nov 2016
51 enrolled
Bronchitis